View Older Stories View More Recent Stories

Nov 1, 2018 08:02PM Form 4 Ra Pharmaceuticals, Inc. For: Nov 01 Filed by: RA CAPITAL MANAGEMENT, LLC
Oct 25, 2018 05:20PM Form SC 13G Eiger BioPharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC
Oct 25, 2018 07:53AM 89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
Oct 23, 2018 08:38AM PlacementTracker Publishes Q3 2018 Private Placement Market League Tables
Oct 5, 2018 04:34PM Form SC 13D/A Kala Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC
Sep 26, 2018 09:16PM Form 3 ARVINAS HOLDING COMPANY, For: Sep 26 Filed by: RA CAPITAL MANAGEMENT, LLC
Sep 26, 2018 07:00AM Lyra Therapeutics Announces $29.5 Million Series B Financing to Advance Innovative Therapeutics for Ear, Nose and Throat Diseases
Sep 12, 2018 08:00AM The Arizona Bioscience Company of the Year is on a Mission to Cure the Uncurable
Sep 5, 2018 12:46PM TeraPore Technologies Unveils New Nanofiltration Membrane Technology at BioProcess International Conference
Aug 14, 2018 04:38PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30
Aug 13, 2018 09:05AM Ivantis Announces FDA Approval for Its Innovative Hydrus® Microstent Device for Minimally Invasive Glaucoma Surgery (MIGS)
Aug 13, 2018 04:00AM Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline
Aug 7, 2018 07:00AM Akouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore and Preserve Hearing
Aug 6, 2018 04:31PM Form SC 13G/A BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
Jul 24, 2018 12:44PM Biopharmaceutical Industry Veteran Marty Siwak joins TeraPore Technologies as Chief Commercial Officer
Jul 19, 2018 08:38AM PlacementTracker Publishes First Half 2018 PIPE Market League Tables
Jul 11, 2018 08:00PM Mitra RxDx Announces $40 Million Financing Round
Jul 10, 2018 04:31PM Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
Jul 2, 2018 04:33PM Form SC 13D Eidos Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Jun 26, 2018 06:00AM Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs
Jun 21, 2018 07:30AM Crinetics Pharmaceuticals Awarded up to $3.2 Million in SBIR Grants for Congenital Hyperinsulinism and Acromegaly
Jun 19, 2018 09:01PM Form 3 Eidos Therapeutics, Inc. For: Jun 19 Filed by: RA CAPITAL MANAGEMENT, LLC
Jun 18, 2018 04:05PM Crinetics Pharmaceuticals Appoints Alan Krasner, M.D., as Chief Medical Officer
May 15, 2018 04:23PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
Apr 30, 2018 08:00AM Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of Synthorin™ Cytokines
Apr 26, 2018 05:38PM Form SC 13G/A InflaRx N.V. Filed by: RA CAPITAL MANAGEMENT, LLC
Apr 16, 2018 07:05AM Ivantis Announces Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial
Apr 12, 2018 09:05AM New Data from the HORIZON Trial of the Hydrus® Microstent Shows Significantly Lower IOP and Medication Use at 24 Months in a US Patient Cohort
Apr 5, 2018 08:00AM Eidos Therapeutics completes $64M Series B financing
Apr 4, 2018 07:30AM Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Apr 2, 2018 04:54PM Form SC 13D BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
Apr 2, 2018 08:13AM RA Capital Management Opposes BioCryst Pharmaceuticals' Proposed Merger with Idera Pharmaceuticals
Apr 2, 2018 08:13AM RA Capital Management Opposes BioCryst Pharmaceuticals' Proposed Merger with Idera Pharmaceuticals
Mar 29, 2018 07:00AM InflaRx Full Year 2017 Financial & Operating Results
Mar 27, 2018 04:21PM Form SC 13D/A Dicerna Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC
Mar 23, 2018 03:34PM The Economist Events Presents: "Healthcare Forum 2018: Financing Healthcare Innovation"
Mar 6, 2018 08:15AM TeraPore Technologies Raises $6M in Oversubscribed Series A Funding Round
Feb 16, 2018 04:43PM Form SC 13D/A Ra Pharmaceuticals, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:54PM Form SC 13G/A AQUINOX PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:52PM Form SC 13G ENDOCYTE INC Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:52PM Form SC 13G Spero Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:43PM Form SC 13D Kala Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:41PM Form SC 13G PROTEON THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:40PM Form SC 13G/A ARCA biopharma, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:40PM Form SC 13G Kadmon Holdings, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:38PM Form SC 13G Krystal Biotech, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:35PM Form SC 13G/A AveXis, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:35PM Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:35PM Form SC 13G/A Strongbridge Biopharma Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2018 05:35PM Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC
View More Recent Stories View Older Stories